PTC THERAPEUTICS, INC. — Director's Dealing 2015

Mar 19, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-03-16

Reporting Person: Kranda Michael L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-16	Common Stock	S	1700	$72.61	Disposed	3042	Direct
2015-03-16	Common Stock	S	800	$73.25	Disposed	2242	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan entered into on August 20, 2014 for the primary purposes of covering tax obligations associated with a restricted stock vesting event and diversification

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $72.00 to $72.98 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $73.02 to $73.52 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.